Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China - read this article along with other careers information, tips and advice on BioSpace
DURHAM, N.C. and BEIJING, March 29, 2022 /PRNewswire/ Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and. | April 3, 2022
La Paz, Jan 3 (EFE).- A senior Bolivian government official who had sparked controversy with his decision to rely on ancestral medicine and not immunize himself against Covid-19 finally received an initial dose of a vaccine on Monday. Several months after inoculations began for his age range, Vice President David Choquehuanca, 60, arrived at around …